Ionis Pharmaceuticals IONS Total Current Assets
Total Current Assets at other companies
Other financials
Where this comes from
Reported directly by Ionis Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:AssetsCurrent.
The official record: Ionis Pharmaceuticals’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ionis Pharmaceuticals's total current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ionis Pharmaceuticals's total current assets?
- Ionis Pharmaceuticals (IONS) reported total current assets of $2.94B in Q1 2026.
- How has Ionis Pharmaceuticals's total current assets changed year-over-year?
- Ionis Pharmaceuticals's total current assets increased by 21.4% year-over-year, from $2.42B to $2.94B.
- What is the long-term trend for Ionis Pharmaceuticals's total current assets?
- Over 5 years (2020 to 2025), Ionis Pharmaceuticals's total current assets has grown at a 7.0% compound annual growth rate (CAGR), from $2.13B to $2.99B.
- What does total current assets mean?
- The total value of all company assets that can be turned into cash within one year.
- How do you interpret total current assets?
- Higher levels indicate stronger liquidity and ability to cover short-term obligations, while a downward trend may signal liquidity pressure.
- How does total current assets compare across companies?
- Benchmark against current liabilities to determine the current ratio, a standard measure of solvency.